Comparison of two amplification technologies for detection and quantitation of human immunodeficiency virus type 1 RNA in the female genital tract. Division of AIDS Treatment Research Initiative 009 Study Team.
Authors:
- 1 July 2000
- journal article
- research article
- Vol. 38 (7) , 2665-9
Abstract
Human immunodeficiency virus type 1 (HIV-1) RNA levels in female genital tract and peripheral blood samples were compared using two commercial amplification technologies: the Roche AMPLICOR HIV-1 MONITOR test and either the Organon Teknika nucleic acid sequence-based amplification (NASBA-QT) assay or the NucliSens assay. Estimates of HIV-1 RNA copy number were derived from internal kit standards and analyzed unadjusted and adjusted to a common set of external standards. We found a discordance rate of approximately 18% between the two technologies for the detection of HIV-1 in either the genital tract or peripheral blood samples. Detection discordance was not consistent among specimens or among women. There were no significant differences in adjusted or unadjusted estimates of HIV-1 RNA copy number in the genital tract samples using the AMPLICOR HIV-1 MONITOR test and either the NASBA-QT assay or the NucliSens assay. In addition, the estimated HIV-1 RNA copy number in peripheral blood samples did not differ when tested with the NucliSens assay and the AMPLICOR HIV-1 MONITOR test using kit standards. However, there was a significant difference in estimated RNA copy number between the NASBA-QT assay and the AMPLICOR HIV-1 MONITOR test for internal kit standards, which, as we have previously shown, was eliminated after adjustment with the external standards. Our results suggest that the Roche and Organon Teknika assays are equivalent for quantifying HIV-1 RNA in female genital tract specimens, although variation in detection does exist.Keywords
This publication has 14 references indexed in Scilit:
- HIV quantitation in spiked vaginocervical secretions: lack of non-specific inhibitory factorsJournal of Virological Methods, 1998
- The Women's Interagency HIV Study. WIHS Collaborative Study Group.1998
- Association between Culturable Human Immunodeficiency Virus Type 1 (HIV‐1) in Semen and HIV‐1 RNA Levels in Semen and Blood: Evidence for Compartmentalization of HIV‐1 between Semen and BloodThe Journal of Infectious Diseases, 1998
- Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratoriesJournal of Clinical Microbiology, 1996
- Quantification of HIV-1 RNA in Plasma: Comparable Results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV Monitor TestJAIDS Journal of Acquired Immune Deficiency Syndromes, 1996
- Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA™ with Amplicor™ reverse transcription-PCR amplification and correlation with quantitative cultureJournal of Virological Methods, 1996
- Multicenter Evaluation Of Quantification Methods For Plasma Human Immunodeficiency Virus Type 1 RnaThe Journal of Infectious Diseases, 1994
- Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infectionJournal of Clinical Microbiology, 1994
- Quantification of HIV-1 RNA in plasma using NASBAtm during HIV-1 primary infectionJournal of Virological Methods, 1993
- Rapid and simple method for purification of nucleic acidsJournal of Clinical Microbiology, 1990